For 5 years, we have been on a mission to make our world a better place, by funding stomach cancer research for a cure, and bringing hope to all those touched by this disease. We have been a part of research and awareness for an underfunded and underrepresented cancer. And we have helped to shape a brighter future for our world. Our work is far from over, but every day, we are taking strides toward a world where cancer is no longer treated, but instead it’s cured.
Today, we are announcing a huge leap forward in that direction, yet again, and we are proud to name our next fund recipient, Vanderbilt University Medical Center, in Nashville. They are leader in the prevention, diagnosis, and treatment of cancer and their world-renowned team of experts provides an integrated, personalized and patient-centered approach to cancer care— including treatment, research, support, education and outreach. Their stomach cancer research focuses on Causes, Diagnosis, and Prediction—and Translates this all into Treatment. Our hope is that our gift will support the advancements of their work, contribute to keeping families whole, and bring our world closer to being cancer free.
Thank you to our amazing donors who have made this all possible. Your continuous belief in what we are doing makes this all a reality, and allows us to continue forward with what we set out to do five years ago: make our world a better, brighter, and cancer free place.
As our world continues to combat COVID-19, we remain committed to social distancing and putting into place measures that keep the disease from spreading. With this in mind, and because of travel precautions, we are hoping to visit Nashville this summer, and cannot wait to formally present our gift to Vanderbilt University Medical Center.
With values of discovery and innovation, impact and translation, relationships and collaboration, and service and compassion, Vanderbilt University Medical Center holds close the same ideals we do, and is at the forefront of groundbreaking cancer research and innovation.
About Vanderbilt University Medical Center
Vanderbilt-Ingram Cancer Center is a National Cancer Institute-designated Comprehensive Cancer Center committed to reducing cancer death and suffering through:
Pioneering research and team science
A team approach to innovative cancer treatment
Evidence-based prevention, education and community outreach
Comprehensive services to meet the unique physical, emotional, psychological and practical needs of cancer survivors after treatment, regardless of age at diagnosis, type of cancer or where they received their oncology care
Located in Nashville, Tennessee, the center in a seven contiguous state region with the highest death rates from cancer. They believe their job is not done until those statistics are changed. Through participation in the network of National Cancer Institute-designated centers, the National Comprehensive Cancer Network and other local, regional and national collaborations, they are dedicated to being a partner with others who share our mission.
About the Program
The Gastrointestinal Cancer Research Program supports basic, translational and clinical research across all GI cancer types, with research focused on:
Causes of GI cancers: Determining the etiology and pathogenesis of gastrointestinal cancers
Diagnosis and Prediction: Developing biomarkers and imaging techniques to improve detection and predict the efficacy of current and novel therapeutics for gastrointestinal cancers.
Models of GI Cancer: Developing and studying novel laboratory models of cancer to improve understanding of human cancers
Translation into Treatment: Translating laboratory discoveries into clinical investigations.
Program Highlights
Below are a few highlights of gastric cancer research projects underway at Vanderbilt University Medical Center:
Study seeking to reverse precancerous stomach lesions.
New insights into the role of H. Pylori in gastric cancer.
Cancer prevention drug plays a dual role in preventing stomach cancer.